Related News:
- FDA approves Roche’s Actemra for the treatment of…
- FDA grants priority review to Xolair (omalizumab)…
- WHO grants prequalification of Actemra/RoActemra for…
- WHO grants prequalification of Actemra/RoActemra for…
- FDA grants Priority Review to Roche’s Lunsumio for…
- FDA grants priority review to Roche’s bispecific…